SMARTSHAPE-project enters final year

On 29-30 January the SMARTSHAPE consortium gathered in Brussels for a combined consortium and review meeting, with the EU Project Officer and our external reviewer.

The meeting marked an important moment of reflection and discussing the next steps of SMARTSHAPE’s continuous blood pressure monitoring technology.

We are a proud partner in SMARTSHAPE delivering project management services, in addition to communication and dissemination.

Coralie Zurstrassen, Project Manager, commented: “The SMARTSHAPE meeting in Brussels was a key milestone for the consortium. It was inspiring to see the very promising results coming together and to get a clear picture of what the future of blood pressure management could look like. We are now entering the final phase of the project, fully aligned and ready to move forward.”

Shifting focus

As SMARTSHAPE enters its final year under the Horizon Europe programme, the focus is shifting toward consolidating the preclinical results and taking the next steps to secure follow-up funding. Increasing the project’s visibility and disseminating the results to the right stakeholders are crucial in this process.

Vera van de Donk, Science Communication Advisor, mentioned: “In this final year, our communication and dissemination efforts will increasingly focus on targeting industry and potential investors. At the same time, continued engagement with the medical community remains a key priority. The SMARTSHAPE technology has many promising applications beyond uncontrolled chronic hypertension and post-stroke patients. Therefore, we are also gathering input from clinicians across different specialties to better understand additional use cases and needs in hypertension monitoring.”

Want to learn more? Explore the patient profiles and how the SMARTSHAPE device could integrate in the clinical workflow.